SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-22-011321
Filing Date
2022-04-29
Accepted
2022-04-29 08:57:23
Documents
5
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2022_def14a-bellicumpharm.htm DEF 14A 755401
2 image_0.jpg GRAPHIC 70468
3 image_1.jpg GRAPHIC 35461
4 image_2.jpg GRAPHIC 41558
5 image_3.jpg GRAPHIC 89041
  Complete submission text file 0001628280-22-011321.txt   1076457
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36783 | Film No.: 22870568
SIC: 2834 Pharmaceutical Preparations